Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CFRA upgrades Generali stock to buy, cites record 2023 operating profit

Published 13/03/2024, 15:56
Updated 13/03/2024, 15:56
© Reuters.

On Wednesday, CFRA analyst raised the rating of Assicurazioni Generali (BIT:GASI) SpA (G:IM) (OTC: ARZGY) from Hold to Buy and increased the price target to €25.00 from €21.00. The upgrade follows Generali's announcement of a record operating profit for 2023, which reached €6.9 billion, a 7.9% year-over-year increase. This performance met consensus estimates and was supported by positive contributions from all business segments, particularly Property-Casualty (P&C).

Generali's gross written premiums saw a 5.6% year-over-year growth, amounting to €82.5 billion. This rise was largely attributed to a significant 12.0% growth in the P&C segment. Additionally, the Life segment's operating profit improved by 1.7%, bolstered by a higher Contractual Service Margin (CSM) release, despite facing some negative one-offs.

In light of these results, Generali has proposed an increased dividend per share (DPS) of €1.28, which marks a 10.3% rise from the previous year. The company also announced a €0.5 billion buyback program. The analyst expressed confidence in Generali's potential to surpass its cash and capital targets set in the Lifetime Partner 24 strategic plan, particularly due to the strong performance in the P&C business.

The CFRA analyst's revised price target of €25.00 is based on a projected 2024 price-to-book (P/B) ratio of 1.4 times, aligning with the average of Generali's peers. Furthermore, CFRA introduced its 2025 earnings per share (EPS) estimate for Generali at €2.58, signaling optimism about the insurer's future financial prospects. The analyst's upgrade to Buy reflects a positive outlook on Generali's improving shareholder remuneration prospects.

InvestingPro Insights

Following the CFRA analyst's upgrade of Assicurazioni Generali SpA (G:IM) (OTC: ARZGY) to Buy, InvestingPro data and insights provide additional context to the insurer's financial health and market position. With a market capitalization of $38.26 billion and a price-to-earnings (P/E) ratio of 8.19, Generali stands as a significant player in the insurance industry. Adjusted for the last twelve months as of Q4 2023, the P/E ratio slightly increases to 9.02, reflecting the company's sustained earnings power relative to its share price.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Tips highlight that Generali's stock typically exhibits low price volatility, an attractive trait for investors seeking stability. Moreover, the company has a track record of maintaining dividend payments for an impressive 32 consecutive years, underscoring its commitment to shareholder returns. This is particularly relevant given Generali's recent proposal to increase its dividend per share (DPS). Additionally, the insurer's liquid assets surpass short-term obligations, indicating a robust liquidity position that supports its operations and strategic initiatives.

While Generali has experienced a decline in revenue growth over the last twelve months, with a decrease of 24.68%, the company's gross profit margin remains at a healthy 17.91%. This suggests that despite revenue challenges, Generali has managed to maintain profitability. The insurer's strong return over the last three months, which is reflected in a price total return of 16.67%, aligns with the CFRA analyst's bullish stance.

For investors seeking a deeper dive into Assicurazioni Generali's performance metrics and strategic positioning, InvestingPro offers additional tips that may guide investment decisions. To explore these insights and benefit from the platform's full suite of tools, readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With 9 more InvestingPro Tips available, investors can gain a comprehensive understanding of Generali's market dynamics and future profitability predictions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.